American Association for Cancer Research, San Antonio Breast Cancer Symposium 2014: Advisors’ Introduction.
- Published in:
- MD Conference Express, 2014, v. 14, n. 56, p. ii, doi. 10.1177/1559897715572350
- By:
- Publication type:
- Article
Works matching IS 15598977 AND DT 2014 AND VI 14 AND IP 56
Results: 21
1
2
Most Genes Associated With Increased Risk of BC Remain Poorly Characterized.
- Published in:
- MD Conference Express, 2014, v. 14, n. 56, p. 28, doi. 10.1177/1559897715572122
- By:
- Publication type:
- Article
3
Radiation Benefits Many but Not Necessarily All Patients With BC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 56, p. 21, doi. 10.1177/1559897715572121
- By:
- Publication type:
- Article
4
Identification of Drivers of Metastasis in BC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 56, p. 14, doi. 10.1177/1559897715572120
- By:
- Publication type:
- Article
5
Update on Epigenetic Agents in the Treatment of BC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 56, p. 30, doi. 10.1177/1559897715572119
- By:
- Publication type:
- Article
6
Highlights and Future Directions in AI Clinical Research.
- Published in:
- MD Conference Express, 2014, v. 14, n. 56, p. 16, doi. 10.1177/1559897715572118
- By:
- Publication type:
- Article
7
Current Perspectives on HER2-Positive BC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 56, p. 17, doi. 10.1177/1559897715572117
- By:
- Publication type:
- Article
8
Overcoming Tumor Diversity and Adaptability Key to Effective Therapies in BC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 56, p. 15, doi. 10.1177/1559897715572116
- By:
- Publication type:
- Article
9
Current Perspectives on Neoadjuvant Treatment of ER-Positive BC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 56, p. 19, doi. 10.1177/1559897715571088
- By:
- Publication type:
- Article
10
Reasons for Rise in CPM Explored.
- Published in:
- MD Conference Express, 2014, v. 14, n. 56, p. 25, doi. 10.1177/1559897715571085
- By:
- Publication type:
- Article
11
New Biology Identified by PGx Is Foundation for New Strategies in BC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 56, p. 2, doi. 10.1177/1559897715571082
- By:
- Publication type:
- Article
12
Harnessing Genomics and Molecular Profiling in ER-Positive BC for New Therapies.
- Published in:
- MD Conference Express, 2014, v. 14, n. 56, p. 4, doi. 10.1177/1559897715571081
- By:
- Publication type:
- Article
13
Heterogeneity, Genome Complexity of TNBC Complicate Therapy.
- Published in:
- MD Conference Express, 2014, v. 14, n. 56, p. 23, doi. 10.1177/1559897715571080
- By:
- Publication type:
- Article
14
Evidence-Based AET in Women Before and After Menopause.
- Published in:
- MD Conference Express, 2014, v. 14, n. 56, p. 13, doi. 10.1177/1559897715571073
- By:
- Publication type:
- Article
15
AC and Weekly Paclitaxel Improve Outcomes in TNBC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 56, p. 7, doi. 10.1177/1559897715571072
- By:
- Publication type:
- Article
16
No Survival Benefit When Adding Everolimus to Trastuzumab and Paclitaxel in Advanced HER2-Positive BC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 56, p. 11, doi. 10.1177/1559897715571071
- By:
- Publication type:
- Article
17
TP53 Mutations Are Associated With Increased Pathologic Complete Response in HER2-Positive BC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 56, p. 8, doi. 10.1177/1559897715571070
- By:
- Publication type:
- Article
18
ICE: No Advantage to Adding Capecitabine to Ibandronate in High-Risk Early BC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 56, p. 9, doi. 10.1177/1559897715571069
- By:
- Publication type:
- Article
19
Partial and Whole Breast Radiation Have Similar Outcomes in Early BC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 56, p. 10, doi. 10.1177/1559897715571064
- By:
- Publication type:
- Article
20
Results From the EPO-ANE-3010 Study Consistent With US Black Box Labeling.
- Published in:
- MD Conference Express, 2014, v. 14, n. 56, p. 12, doi. 10.1177/1559897715571063
- By:
- Publication type:
- Article
21
TNT Results: Carboplatin Improves Patient Outcomes in Advanced BRCA1/2-Mutated BC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 56, p. 6, doi. 10.1177/1559897715571062
- By:
- Publication type:
- Article